Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qing Cong, Ling Lin, Biao Qi, Congjian Xu & Xiaoyan Zhang. (2021) Human Chorionic Gonadotropin Polypeptide Nanoparticle Drug Delivery System Improves Methotrexate Efficacy in Gestational Trophoblastic Neoplasia in vitro. Cancer Management and Research 13, pages 1699-1708.
Read now
Read now
Seham M. Ragab & Eman A. Badr. (2016) Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity. Hematology 21:2, pages 78-91.
Read now
Read now
Articles from other publishers (31)
Sheng‐Fan Wang, Kuan‐Wei Huang, Yueh‐Ching Chou, Hsin‐Chen Lee, Po‐Kuei Wu, Wei‐Ming Chen, Giun‐Yi Hung & Yuh‐Lih Chang. (2023)
Effect of c
o‐medications
and potential risk factors of
high‐dose methotrexate‐mediated
acute hepatotoxicity in patients with osteosarcoma
. Cancer Medicine 12:11, pages 12354-12364.
Crossref
Crossref
Joseph P. Eder & Navid Hafez. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
13
.
Praful Pandey, Ahitagni Biswas, Saphalta Baghmar, Mukesh Patekar & Ranjit Kumar Sahoo. 2022. Lymphoma. Lymphoma.
Pedro Gustavo Barros Rodrigues, Talles Tavares de Lima, Fernando Barroso Duarte & Paulo Ribeiro Nóbrega. (2022) Myelopathy associated with intrathecal methotrexate. Practical Neurology 22:2, pages 141-144.
Crossref
Crossref
Justine Solignac, Laure Farnault, Thomas Robert, Raphaelle Fanciullino, Sylvain Choquet, Philippe Brunet, Geoffroy Venton & Mickaël Bobot. (2022) Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient. Nefrología (English Edition) 42:2, pages 130-134.
Crossref
Crossref
Justine Solignac, Laure Farnault, Thomas Robert, Raphaelle Fanciullino, Sylvain Choquet, Philippe Brunet, Geoffroy Venton & Mickaël Bobot. (2022) Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient. Nefrología 42:2, pages 130-134.
Crossref
Crossref
Giovanni Di Lorenzo, Giuseppe Mirenda, Serena Springer, Maria Teresa Mirandola, Francesco Paolo Mangino, Federico Romano & Giuseppe Ricci. (2022) Hysteroscopic Treatment of Cervical Pregnancy: A Scoping Review of the Literature. Journal of Minimally Invasive Gynecology 29:3, pages 345-354.e1.
Crossref
Crossref
Jason N. Barreto, Joel M. Reid, Carrie A. Thompson, Kristin C. Mara, Andrew D. Rule, Kianoush B. Kashani, Nelson Leung, Thomas R. Larson, Renee M. McGovern, Thomas E. Witzig & Erin F. Barreto. (2021) Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function. Clinical and Translational Science 15:1, pages 105-117.
Crossref
Crossref
Andrea Morales-Martinez, Fernando Lozano-Sanchez, Alberto Duran-Peña, Khe Hoang-Xuan & Caroline Houillier. (2021) Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives. Cancers 13:14, pages 3479.
Crossref
Crossref
Catherine E. DeFino, Jason N. Barreto, Amanda G. Pawlenty, Michael W. Ruff, Ivan D. Carabenciov, Kristin C. Mara & Carrie A. Thompson. (2021) Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:5, pages 430-439.
Crossref
Crossref
Xiaoli Chang, Yixian Guo, Li Su, Yunxiu Zhang, Wuhan Hui, Hong Zhao, Ronghua Hu & Wanling Sun. (2021) Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 21:2, pages 91-96.
Crossref
Crossref
Uvette Lou, Jamie Kwok, Thu Anne Nguyen, Allen Zhou & Samantha O. Luk. (2019) Effect of Levetiracetam on Time to High‐Dose Methotrexate Clearance in Patients With Hematologic Malignancies. The Journal of Clinical Pharmacology 60:3, pages 324-330.
Crossref
Crossref
Biljana Škorić, Marija Jovanović, Branislava Miljković, Miloš Kuzmanović & Katarina Vučićević. (2020) Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients. Arhiv za farmaciju 70:1, pages 20-33.
Crossref
Crossref
William N. Hait & Joseph P. Eder. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
15
.
Pritam Kataria, Pradip Kendre, Apurva Patel, Nahush Tahiliani & Sushant Ikhar. (2018) Methotrexate-induced toxic epidermal necrolysis: A rare case report and review of literature. Indian Journal of Critical Care Medicine 22:10, pages 740-742.
Crossref
Crossref
Craig A. Vargo, Leslie A. Ray & Herbert B. Newton. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
275
310
.
William N. Hait & Joseph P. Eder. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
14
.
Yedidia Bentur & Yael Lurie. 2017. Critical Care Toxicology. Critical Care Toxicology
1171
1218
.
Alessia Dalla Pria, Maggie Bendle, Ramya Ramaswami, Marta Boffito & Mark Bower. (2015) The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy. Cancer Chemotherapy and Pharmacology 77:3, pages 653-657.
Crossref
Crossref
Yedidia Bentur & Yael Lurie. 2016. Critical Care Toxicology. Critical Care Toxicology
1
49
.
S Jabeen, L Holmboe, G I G Alnæs, A M Andersen, K S Hall & V N Kristensen. (2015) Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. The Pharmacogenomics Journal 15:5, pages 385-390.
Crossref
Crossref
Brigitte C. Widemann, Stefan Schwartz, Nalini Jayaprakash, Robbin Christensen, Ching-Hon Pui, Nikhil Chauhan, Claire Daugherty, Thomas R. King, Janet E. Rush & Scott C. Howard. (2014) Efficacy of Glucarpidase (Carboxypeptidase G2) in Patients with Acute Kidney Injury After High-Dose Methotrexate Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:5, pages 427-439.
Crossref
Crossref
Riccardo Soffietti, Elisa Trevisan & Roberta Rudà. 2014. Neurologic Aspects of Systemic Disease Part III. Neurologic Aspects of Systemic Disease Part III
1199
1218
.
Moon Ki Choi, Eun Suk Kang, Dae Won Kim, Yonug Hyeh Ko, Hyeri Seok, Jin Hong Park, Dae Hee Pyo, Do Hoon Lim, Seok Jin Kim & Won Seog Kim. (2013) Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation. International Journal of Hematology 98:3, pages 346-354.
Crossref
Crossref
Nicole Bergner, Ina Monsef, Gerald Illerhaus, Andreas Engert & Nicole Skoetz. (2012) Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Herbert B. Newton. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
903
916
.
Nicole Bergner, Sabine Kluge, Ina Monsef, Gerald Illerhaus, Andreas Engert & Nicole Skoetz. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jai Grewal, Marlon Saria, Harpreet K Grewal & Santosh Kesari. (2011) Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome. Clinical Investigation 1:10, pages 1391-1402.
Crossref
Crossref
Christopher J. Campen, Rebecca L. Tombleson & Myke R. Green. (2010) High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma. Journal of Neuro-Oncology 101:3, pages 345-355.
Crossref
Crossref
William R. Shapiro, Conrad E. Johanson & Willem Boogerd. (2009) Treatment Modalities for Leptomeningeal Metastases. Seminars in Oncology 36, pages S46-S54.
Crossref
Crossref
Myke R. Green & Marc C. Chamberlain. (2008) Renal dysfunction during and after high-dose methotrexate. Cancer Chemotherapy and Pharmacology 63:4, pages 599-604.
Crossref
Crossref